Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Biopreservation and Biobanking
|
April 29, 2024
The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks
Hein S Zelisse, Sander de Ridder, Mignon D J M van Gent, et al.
Histopathology
|
February 5, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group
Ylva A Weeda, Roberto Salgado, Filip van Herpe, et al.
The New England Journal of Medicine
|
May 11, 2017
Cancer-Associated Mutations in Endometriosis without Cancer
Michael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, et al.
Cancer Cell
|
September 8, 2023
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
Beiping Miao, Zhaoqing Hu, Riccardo Mezzadra, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Nature Cancer
|
February 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Gynecologic and Obstetric Investigation
|
November 30, 2022
Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research
Hein S Zelisse, Mignon D J M van Gent, Sander de Ridder, et al.
Nature Medicine
|
May 16, 2019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature Medicine
|
June 19, 2019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature Medicine
|
September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Iris Nederlof, Olga I Isaeva, Manon de Graaf, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Biopreservation and Biobanking
|
April 29, 2024
The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks
Hein S Zelisse, Sander de Ridder, Mignon D J M van Gent, et al.
Histopathology
|
February 5, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group
Ylva A Weeda, Roberto Salgado, Filip van Herpe, et al.
The New England Journal of Medicine
|
May 11, 2017
Cancer-Associated Mutations in Endometriosis without Cancer
Michael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, et al.
Cancer Cell
|
September 8, 2023
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
Beiping Miao, Zhaoqing Hu, Riccardo Mezzadra, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Nature Cancer
|
February 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC
Noah F Greenwald, Iris Nederlof, Cameron Sowers, et al.
Gynecologic and Obstetric Investigation
|
November 30, 2022
Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research
Hein S Zelisse, Mignon D J M van Gent, Sander de Ridder, et al.
Nature Medicine
|
May 16, 2019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature Medicine
|
June 19, 2019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Nature Medicine
|
September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Iris Nederlof, Olga I Isaeva, Manon de Graaf, et al.
Page
of 11